This is a preview of subscription content, access via your institution.
Funding
This work was funded by a grant from the Athena Foundation. This study was presented in poster format at the Society of Surgical Oncology 2022 International Conference on Surgical Cancer Care, 9–12 March 2022, Houston, TX.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
C.H. is a former employee and current stockholder of Color Genomics. H.H.C. discloses research funds to institution from Clovis Oncology, Color Genomics, Janssen, Medivation, Phosplatin, and Sanofi, consultant for AstraZeneca, and royalties from UpToDate. J.G.S. discloses scientific advisory board of Teryx. The other authors have nothing to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Clark, N.M., Roberts, E.A., Federenko, C. et al. ASO Visual Abstract: Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers. Ann Surg Oncol 30, 1329–1330 (2023). https://doi.org/10.1245/s10434-022-12800-w
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12800-w